HIV: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

No stopped trial with a stated reason in this view.

Trials whose registry record says individual participant data (IPD) will be shared.

• Olfactory Function and Model-Based Behavior in People Living With HIV and SUD

  NCT07637669· National Institute on Drug Abuse (NIDA)· Source

• Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer

  NCT02108028· National Cancer Institute (NCI)· Source

• PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia

  NCT04926922· National Institute of Allergy and Infectious Diseases (NIAID)· Source

• A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV)

  NCT05996471· ViiV Healthcare· Source

• Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)

  NCT06134362· ViiV Healthcare· Source

• First Time in Human Study of Long Acting VH4524184 Formulations

  NCT06310551· ViiV Healthcare· Source

• Investigating the Optimal Management of Dolutegravir Resistance

  NCT06762054· University of Nairobi· Source

• A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants

  NCT05418868· ViiV Healthcare· Source

• Community, Home-based Education, Screening Services Strategy to Increase Cervical Cancer Control Access for HIV-Positive Women in Nigeria

  NCT06751030· Emory University· Source

• A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)

  NCT07266831· Merck Sharp & Dohme LLC· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 21
• Organoids 6
• Mendelian Randomization Analysis 7
• CRISPR-Cas Systems 27
• Gene Expression Profiling 62
• Sequence Analysis, RNA 5
• Whole Genome Sequencing 15
• Exome Sequencing 3
• Proteomics 37
• Metabolomics 32
• Mass Spectrometry 16
• Flow Cytometry 45
• Immunohistochemistry 15
• Xenograft Model Antitumor Assays 3
• Positron-Emission Tomography 4
• Magnetic Resonance Imaging 77
• Machine Learning 71
• Deep Learning 20
• Cohort Studies 424
• Genome-Wide Association Study 20

• Time Series Transformer for long-term CD4 trajectory prediction in HIV patients: a novel deep learning approach.

  Front Cell Infect Microbiol, Aug 2026

• PAC-Net: A physics-guided multimodal hybrid network for antibody-antigen interaction prediction.

  J Biomed Inform, Aug 2026

• Constructing a novel chimeric multiepitope vaccine against Simian immunodeficiency virus accessory proteins: Using hybrid deep learning algorithms and bioinformatics-driven tools.

  Comput Biol Chem, Aug 2026

• Developing nonlinear time-varying weighted combined prediction framework for infectious diseases: validation with respiratory infectious diseases and sexually transmitted infections.

  BMC Public Health, Aug 2026

• Forecasting monthly AIDS incidence in China via LSTM-CNN parallel fusion: a comparative study of 10 predictive models.

  Front Public Health, Jul 2026

• Deep Contrastive Learning for High-Throughput Prediction of Drug Resistance Mutations from Sequences.

  Adv Sci (Weinh), Jul 2026

• Public antibody clonotypes and deep learning identify SARS-CoV-2 and HIV broadly neutralizing antibodies in immune repertoires.

  Cell Rep, Jun 2026

• PhyloCNN: Improving Tree Representation and Neural Network Architecture for Deep Learning from Trees in Phylodynamics and Diversification Studies.

  Syst Biol, Jun 2026

• Using deep learning to identify brain networks mediating cognitive and motor impairments in alcohol use disorder.

  Transl Psychiatry, May 2026

• Is the molecular microenvironment of the latent HIV reservoir predictable using deep learning approaches?

  J Virol, Apr 2026

See which targets of this disease your abstract mentions, and go to the people working on them.